Why BioXcel Therapeutics Stock Is Slumping Today

Why BioXcel Therapeutics Stock Is Slumping Today
·2 min read

What happened Shares of BioXcel Therapeutics (NASDAQ: BTAI) were down by 11.6% as of 3:08 p.m. ET Wednesday. The biotech's shares are retreating today in response to the Food and Drug Administration's decision to extend the review date under the Prescription Drug User Fee Act (PDUFA) for the New Drug Application of BXCL501 for the acute treatment of agitation associated with schizophrenia and bipolar disorders I and II.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting